WHAT WE HOPE TO UNDERSTAND
HOME
ABOUT
Who We Are
Contact Us
LEARN MORE
RP Community
In The News
GENETIC INSIGHTS
ARHGEF18
CA4
CLRN1
CRB1
DHDDS
INPP5E
LRAT
PRPF31
RP17
RPE65
RPGR
SNRNP200
USH2A
FUNDRAISING
Events
More
Use tab to navigate through the menu items.
MAKE A DONATION
Profile
Join date: Mar 6, 2021
Posts
Jul 13, 2021
∙
2 min
CRISPR/Cas9 Gene Editing
X-linked RP caused by RPGR mutations, an attractive target for gene therapy because of its clinical severity and large number of patients.
7
0
Mar 7, 2021
∙
2 min
Genome Editing in Retinal Diseases using CRISPR Technology
By: Glenn Yiu, MD, PhD - Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, California Ophthalmology
9
0
Jun 10, 2020
∙
1 min
New gene therapy technique
Shows promise in stem cell model of retinitis pigmentosa Although the 2017 FDA approval of Spark Therapeutics’ gene therapy Luxturna was...
1
0
Load More
Academic Paper
Writer
0
Followers
0
Following
Follow
Following icon
More actions
Profile
Events
More
Use tab to navigate through the menu items.